Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper
Guardado en:
Autores principales: | Huizhi Zhang, Guennadi Kozlov, Xinlu Li, Howie Wu, Irina Gulerez, Kalle Gehring |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/447c938499dd41cd8e9f8da85f7b9141 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Huizhi Zhang, et al.
Publicado: (2017) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Min Thura, et al.
Publicado: (2019) -
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Min Thura, et al.
Publicado: (2021) -
Crystal structure of an archaeal CorB magnesium transporter
por: Yu Seby Chen, et al.
Publicado: (2021) -
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
por: Dylan R. Rivas, et al.
Publicado: (2021)